See more : Silver Bull Resources, Inc. (SVBL) Income Statement Analysis – Financial Results
Complete financial analysis of Cresco Labs Inc. (CRLBF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cresco Labs Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- TradeUP Global Corporation (TUGCU) Income Statement Analysis – Financial Results
- OFX Group Limited (OFX.AX) Income Statement Analysis – Financial Results
- Cummins Inc. (0I58.L) Income Statement Analysis – Financial Results
- Delta Asia International Corporation (6762.TWO) Income Statement Analysis – Financial Results
- New Sparkle Roll International Group Limited (0970.HK) Income Statement Analysis – Financial Results
Cresco Labs Inc. (CRLBF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.crescolabs.com
About Cresco Labs Inc.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 770.89M | 842.68M | 821.68M | 476.25M | 128.53M | 43.25M | 10.31M | 3.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 441.00M | 435.67M | 415.34M | 192.31M | 64.45M | 2.84M | 9.16M | 14.57 | 61.11 | 82.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 329.89M | 407.01M | 406.35M | 283.94M | 64.08M | 40.42M | 1.15M | 3.16M | -61.11 | -82.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 42.79% | 48.30% | 49.45% | 59.62% | 49.86% | 93.45% | 11.17% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 1.99M | 370.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 36.81M | 54.99M | 40.34M | 160.94M | 77.15M | 29.16M | 44.42K | 42.84K | 49.32K | 49.32K | 205.78K | 341.29K | 311.56K | 338.34K | 439.16K | 300.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 8.30M | 15.58M | 29.73M | 19.03M | 12.63M | 2.05M | 455.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.45K | 8.44K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 31.81K | 16.46K |
| SG&A | 259.81M | 350.65M | 317.80M | 179.97M | 89.78M | 31.21M | 44.42K | 42.84K | 49.32K | 49.32K | 205.78K | 341.29K | 311.56K | 338.34K | 440.60K | 308.96K | 673.66K | 442.67K | 1.56M | 437.22K | 244.28K | 130.92K | 45.36K | 31.81K | 16.46K |
| Other Expenses | 151.02M | -572.00K | 753.00K | 48.13M | 8.56M | 27.00K | 663.85 | 9.23K | 9.91K | 9.09K | 53.77K | 70.09K | 227.95K | 253.46K | 22.40K | -303.78K | 1.07K | 21.70K | 766.91 | 1.16K | -119.15K | 127.65K | 209.13K | 319.18K | 231.94K |
| Operating Expenses | 435.36M | 350.08M | 318.56M | 228.10M | 98.34M | 33.82M | 44.42K | 42.86K | -55.99K | 60.27K | 208.32K | 380.51K | 339.52K | 338.89K | 440.98K | 310.51K | 674.73K | 444.15K | 1.56M | 441.25K | 244.28K | 130.92K | 89.48K | 350.99K | 248.41K |
| Cost & Expenses | 858.71M | 785.75M | 733.89M | 420.41M | 162.79M | 36.65M | 44.42K | 42.86K | -55.99K | 60.27K | 208.32K | 380.51K | 339.52K | 338.89K | 440.98K | 310.51K | 674.73K | 444.15K | 1.56M | 441.25K | 244.28K | 130.92K | 89.48K | 350.99K | 248.41K |
| Interest Income | 2.42M | 679.00K | 938.00K | 1.41M | 1.58M | 89.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.96K | 18.40K | 0.00 | 1.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 63.24M | 58.52M | 52.15M | 40.91M | 9.46M | 89.00K | 41.60K | 30.81K | 26.49K | 33.62K | 48.18K | 39.92K | 39.75K | 49.55K | 32.63K | 3.78K | 0.00 | 1.10M | 0.00 | 0.00 | 182.35K | 0.00 | 0.00 | 132.58K | 0.69 |
| Depreciation & Amortization | 70.57M | 55.44M | 44.55M | 38.70M | 12.19M | 2.17M | 646.00K | 14.57 | 61.53 | 82.48 | 116.50 | 158.61 | 194.51 | 542.64 | 374.50 | 1.55K | 1.07K | 1.49K | 766.91 | 1.61 | 126.41K | 1.31 | 44.13K | 46.75K | 34.57K |
| EBITDA | -14.62M | -10.24M | -157.04M | 6.75M | -30.09M | 9.66M | -3.48M | -33.61K | 73.43K | -84.07K | -154.56K | -322.46K | 4.52K | -2.23M | -2.88M | -2.03M | -559.24K | -979.09K | -1.56M | -441.25K | -181.08K | -130.92K | -31.58K | -304.24K | -213.84K |
| EBITDA Ratio | -1.90% | 14.65% | 16.18% | 20.65% | -13.77% | 23.84% | -0.42% | -1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -87.82M | 65.75M | 87.97M | 58.31M | -34.26M | 4.95M | -44.42K | -33.63K | 65.89K | -51.18K | -154.55K | -310.43K | -379.27K | -388.43K | -473.61K | -595.88K | -674.73K | -1.00M | -1.56M | -441.25K | -307.49K | -130.92K | -103.26K | -350.99K | -248.41K |
| Operating Income Ratio | -11.39% | 7.80% | 10.71% | 12.24% | -26.65% | 11.43% | -0.43% | -1.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -59.08M | -42.61M | -39.38M | -40.71M | -28.95M | -1.29M | 139.77K | 53.05K | 96.42K | -56.92K | 5.59K | 20.51K | 186.63K | -1.89M | -2.44M | -1.72M | 90.18K | -537.39K | 43.16K | 1.16K | -182.35K | 127.65K | 195.35K | -132.58K | -0.69 |
| Income Before Tax | -146.90M | -126.91M | -256.73M | 7.16M | -50.84M | 7.47M | -85.35K | -108.03K | 47.38K | -117.44K | -202.74K | -361.38K | -151.32K | -85.43K | -2.91M | -2.05M | -584.55K | -981.24K | -1.51M | -440.09K | -489.85K | -3.27K | 92.09K | -483.57K | -248.41K |
| Income Before Tax Ratio | -19.06% | -15.06% | -31.24% | 1.50% | -39.55% | 17.26% | -0.83% | -3.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 32.95M | 88.94M | 40.11M | 43.72M | 14.46M | 4.37M | -663.85 | 43.59K | -7.98K | 32.64K | 0.00 | 11.03K | -342.40K | 4.03M | 2.47M | -19.39K | -90.18K | 1.10M | -146.31K | -3.00K | 131.48K | -116.13K | -158.23K | 132.58K | 0.69 |
| Net Income | -175.52M | -215.84M | -296.83M | -36.56M | -65.30M | -1.92M | -85.35K | -108.03K | 47.38K | -117.44K | -202.74K | -361.38K | -36.87K | -2.28M | -2.91M | -2.03M | -584.55K | -981.24K | -1.37M | -438.25K | -438.97K | -14.79K | 82.52K | -483.57K | -248.41K |
| Net Income Ratio | -22.77% | -25.61% | -36.13% | -7.68% | -50.81% | -4.43% | -0.83% | -3.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.54 | -0.72 | -1.13 | -0.17 | -0.55 | -0.03 | -2.45 | -3.10 | 1.16 | -3.38 | -5.82 | -10.38 | -1.11 | -77.44 | -108.25 | -78.24 | -24.14 | -44.38 | -71.04 | -29.14 | -43.91 | -1.76 | 15.37 | -86.80 | -67.23 |
| EPS Diluted | -0.54 | -0.72 | -1.13 | -0.17 | -0.55 | -0.03 | -2.45 | -3.10 | 1.16 | -3.37 | -5.82 | -10.38 | -1.11 | -77.44 | -108.25 | -78.24 | -24.14 | -44.38 | -71.04 | -29.14 | -43.91 | -1.76 | 15.37 | -86.80 | -67.23 |
| Weighted Avg Shares Out | 323.82M | 298.16M | 262.33M | 210.47M | 118.32M | 59.34M | 34.79K | 34.79K | 34.79K | 34.79K | 34.81K | 34.81K | 33.17K | 29.39K | 26.89K | 25.89K | 24.21K | 22.11K | 19.24K | 15.04K | 10.00K | 8.38K | 6.21K | 5.57K | 3.70K |
| Weighted Avg Shares Out (Dil) | 323.82M | 298.16M | 262.33M | 210.47M | 118.32M | 59.34M | 34.81K | 34.81K | 34.81K | 34.81K | 34.81K | 34.81K | 33.17K | 29.39K | 26.89K | 25.89K | 24.21K | 22.11K | 19.24K | 15.04K | 10.00K | 8.38K | 6.21K | 5.57K | 3.70K |
Despite Fast-paced Momentum, Cresco Labs Inc. (CRLBF) Is Still a Bargain Stock
Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our...
Florida Supreme Court OKs adult-use cannabis referendum for November ballot in victory for pot companies
The Florida Supreme Court on Monday ruled in favor of allowing Florida voters to decide whether cannabis can be sold to adults 21 and over through a referendum on the November ballot.
Cresco Labs Inc. (CRLBF) Upgraded to Strong Buy: Here's What You Should Know
Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
2 Marijuana Companies That Have Recently Turned Profits
Legal obstacles make turning a profit in the marijuana industry a challenge. Cresco Labs and Green Thumb Industries have been notable exceptions, however.
3 Cannabis Stocks to Buy Before the Coming Pre-Election Rally
When Joe Biden assumed power in January 2021, cannabis stocks skyrocketed. The reason was hopes of federal level legalization.
Cresco Labs Inc. (CRLBF) Is Attractively Priced Despite Fast-paced Momentum
Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our...
Cresco Labs Inc. (CRLBF) Q4 Earnings and Revenues Surpass Estimates
Cresco Labs Inc. (CRLBF) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.03 per share a year ago.
Cresco Labs Inc. (CRLBF) Q4 2023 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) Q4 2023 Earnings Call Transcript
Cannabis company Cresco Labs swings to a profit while revenue beats estimates
Cresco Labs Inc. CRLBF, +2.63% said Wednesday it swung to a fourth-quarter profit on stronger-than-expected revenue. The Chicago-based cannabis seller said it earned $4.87 million in the three months ended Dec. 31.
Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements
CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements.
Source: https://incomestatements.info
Category: Stock Reports